SRL Diagnostics, a prominent diagnostic chain in India and a subsidiary of Fortis Healthcare, has announced its rebranding as Agilus Diagnostics. The new name, Agilus, is derived from the Latin term “agilis,” which means agility. The company’s CEO, K. Anand, expressed excitement about the new identity, highlighting the brand transformation efforts undertaken over the past few years.
Anand stated, “We are excited to adopt this new identity that is a culmination of our efforts on brand transformation over the past few years. We are certain that it will create momentum for the company’s upcoming growth phase.” He further emphasized that although the name has changed, the company’s core principles and business fundamentals remain intact. Agilus Diagnostics aims to collaborate closely with its partners to ensure a seamless brand transition in the coming days.
Agilus Diagnostics has established an extensive laboratory network, encompassing more than 410 labs and serving over 3,700 customer touchpoints. With a presence in 1,000 towns and cities across India, the company serves a wide range of clients, including approximately 12,000 direct clients. In the fiscal year 2022-23, Agilus Diagnostics catered to over 16.6 million patients and conducted a remarkable 39.1 million tests.
The rebranding initiative reflects the company’s commitment to adaptability and agility in the ever-evolving healthcare landscape. By embracing a new identity, Agilus Diagnostics aims to reinforce its position as a leading player in the diagnostic industry while continuing to deliver high-quality services to its vast customer base.
The healthcare industry has witnessed significant advancements and transformations, with diagnostics playing a crucial role in disease prevention, diagnosis, and treatment. Agilus Diagnostics recognizes the importance of staying at the forefront of innovation and leveraging technology to enhance patient care. Through its network of laboratories and customer touchpoints, the company strives to provide accurate and reliable diagnostic services, contributing to better healthcare outcomes for individuals across India.
As the brand transition unfolds, Agilus Diagnostics remains dedicated to maintaining strong partnerships and collaborative relationships with healthcare providers, hospitals, and other stakeholders in the industry. By working together, the company aims to drive further advancements in the field of diagnostics and contribute to the overall improvement of healthcare services in the country.
With the rebranding as Agilus Diagnostics, the company is poised to embark on a new chapter of growth and expansion. By embracing agility and innovation, Agilus Diagnostics aims to strengthen its position in the market and continue its mission of providing accessible and high-quality diagnostic services to communities across India.
As the healthcare industry continues to evolve, Agilus Diagnostics is committed to adapting to changing needs and delivering exceptional diagnostic solutions that positively impact patient outcomes. The new brand identity reflects the company’s vision for the future and its unwavering dedication to excellence in healthcare diagnostics.
With an extensive laboratory network comprising over 410 labs, Agilus Diagnostics has a strong presence in more than 1,000 towns and cities across India. The company serves a wide range of clients, including over 12,000 direct clients and operates through 3,700 customer touchpoints. In the fiscal year 2022-23, Agilus Diagnostics served an impressive total of over 16.6 million patients and conducted 39.1 million tests, highlighting its significant contribution to the healthcare sector.
The rebranding initiative underscores Agilus Diagnostics’ commitment to remaining at the forefront of the rapidly evolving healthcare landscape. By embracing a new identity, the company aims to reinforce its position as a leading player in the diagnostic industry while continuing to deliver high-quality services to its extensive customer base.
As diagnostics play a pivotal role in disease prevention, diagnosis, and treatment, Agilus Diagnostics recognizes the importance of innovation and technology in advancing patient care. The company strives to leverage the latest advancements in the field to provide accurate and reliable diagnostic services, ultimately contributing to better healthcare outcomes for individuals across India.
Overall, the rebranding of SRL Diagnostics as Agilus Diagnostics marks an important milestone in the company’s journey. With a renewed focus on agility and innovation, Agilus Diagnostics is poised to shape the future of diagnostics in India and make a lasting impact on the healthcare landscape.
